The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment for adults whose depression has not responded adequately ...

Magnus Medical, Inc., the company behind SAINT(R), the first and only FDA-cleared, rapid-remission therapy for Major Depressive Disorder (MDD), today announced that the Centers for Medicare & Medicaid ...

CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...

With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...

A noninvasive neuromodulation therapy that sends electrical microcurrents through a person’s hand can enhance sleep quality and overall health in older adults, a new study finds. The therapy, which is ...

An image of a patient undergoing electroconvulsive shock therapy at UW Medical Center – Northwest. (KOMO News) WASHINGTON STATE — Sylvie Sallquist has struggled with severe depression and anxiety ...